Oxford's HIV vaccine starts Phase 1 clinical trials in the UK
A
novel HIV vaccine, developed at the University of Oxford in the wake of
Covid-19 vaccine success, is to be trialled on humans. The goal of the
trial, ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.